Die Bedeutung des Fettsuretransporters L-Carnitin bei nicht-alkoholischer Fettlebererkrankung (NAFLD)
Heres the deal: Ozempic, Wegovy, and other GLP-1s dont necessarily make you cold
Compound Versions of Weight-Loss Drugs Will Soon No Longer Be Allowed, FDA Rules, ABC News, 2025
Recent research has suggested that GLP-1 agonists used to treat obesity might be associated with a stroke in the optic nerve, but association is not the same as causation
What the EMA Found and Why It Matters The EMAs Pharmacovigilance Risk Assessment Committee (PRAC) completed an exhaustive review of semaglutide, including data from clinical trials, post-marketing surveillance, non-clinical studies, and medical literature, and concluded that NAION is a very rare but real adverse effect of taking semaglutide